Clinical trial
Thymus Transplantation in DiGeorge Syndrome #668
NCT00576407 · Sumitomo Pharma Switzerland GmbH, Industry · Completed
Key facts
| NCT number | NCT00576407 |
|---|---|
| Title | Thymus Transplantation in DiGeorge Syndrome #668 |
| Official title | Phase II Study of Thymus Transplantation in Complete DiGeorge Syndrome #668 |
| Lead sponsor | Sumitomo Pharma Switzerland GmbH, Industry |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | DiGeorge Syndrome, Complete Typical DiGeorge Anomaly |
| Intervention type | Biological |
| Interventions | Cultured Thymus Tissue for Implantation (CTTI) |
| Enrollment | 26 |
| Start date | Oct 1, 1991 |
| Primary completion | Apr 1, 2009 |
| Completion | Dec 31, 2017 |
| First posted | Dec 19, 2007 |
| Last update posted | Mar 25, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: